期刊论文详细信息
Particle and Fibre Toxicology
Immediate efficacy and persistent speed of kill of a novel oral formulation of afoxolaner (NexGardTM) against induced infestations with Ixodes ricinus ticks
Frederic Beugnet3  Diane Larsen2  Karine Chalvet-Monfray1  Wilfried Lebon3  Lénaïg Halos3 
[1] INRA, UR346 d ’ Epidémiologie Animale, Université de Lyon, VetAgro Sup Campus Vétérinaire de Lyon, 1 Avenue Bourgelat, 69280 Marcy-l’Étoile, France;Merial Limited, 3239 Satellite Blvd, Duluth, GA 30096, USA;Merial S.A.S., Sanofi Pasteur confluence, 69007 Lyon, France
关键词: Chewable treatment;    Immediate efficacy;    Speed of kill;    Dog;    Afoxolaner;    Tick;    Ixodes ricinus;   
Others  :  1150084
DOI  :  10.1186/1756-3305-7-452
 received in 2014-08-22, accepted in 2014-09-15,  发布年份 2014
PDF
【 摘 要 】

Background

Ticks are hematophageous arthropods that transmit a wide spectrum of pathogens to human and animals. The ability of an acaricidal product to kill ticks quickly provides an important added benefit, especially as protecting dogs from tick bites remains the best preventive measure against tick-borne diseases. The speed of kill of afoxolaner in a novel soft chewable formulation (NexGardTM) against induced infestations with Ixodes ricinus adult ticks was evaluated during a full-month negative controlled and blinded study following a single oral administration.

Methods

12 healthy beagle dogs were included and randomly allocated to 2 groups of six dogs each. One Group was a negative control while the other group was treated with an oral formulation of afoxolaner on Day 0. Tick infestations with 40 (±5) female and 10 male adult unfed I. ricinus were performed on Days -1, 7, 14, 21 and 28. To evaluate immediate efficacy, the number of live ticks were thumb counted at 12 and 24 hours post treatment. To evaluate the persistent speed of kill following further infestations, ticks were thumb counted 12 and 24 hours post infestations. Ticks were removed 24 hours post treatment or infestation.

Results

Afoxolaner starts to kill the pre-existing tick infestations rapidly with an immediate efficacy of 93.4% and 100% respectively at 12 h and 24 h post treatment. The persistent speed of kill of afoxolaner was significant (p < 0,05), as compared with untreated controls, at 12 hours after infestations at D7 and D21. Efficacy at 12 h was 76.6%, 41.9%, 36.9% and 38.5% at D7, D14, D21 and D28 respectively. Efficacy at 24 h ranged from 91% to 100% for the entire month.

Conclusions

This study demonstrated that besides the excellent acaricidal efficacy of afoxolaner after single oral administration, the product has a rapid speed of kill against one of the most important European tick species and controlled the weekly re-infestations for 28 days post treatment.

【 授权许可】

   
2014 Halos et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150405135432581.pdf 161KB PDF download
【 参考文献 】
  • [1]Chomel B: Tick-borne infections in dogs-an emerging infectious threat. Vet Parasitol 2011, 179(4):294-301.
  • [2]Dantas-Torres F, Chomel BB, Otranto D: Ticks and tick-borne diseases: a One Health perspective. Trends Parasitol 2012, 28(10):437-446.
  • [3]Medlock JM, Hansford KM, Bormane A, Derdakova M, Estrada-Peña A, George JC, Golovljova I, Jaenson TG, Jensen JK, Jensen PM, Kazimirova M, Oteo JA, Papa A, Pfister K, Plantard O, Randolph SE, Rizzoli A, Santos-Silva MM, Sprong H, Vial L, Hendrickx G, Zeller H, Van Bortel W: Driving forces for changes in geographical distribution of Ixodes ricinus ticks in Europe. Parasit Vectors 2013, 6:1. BioMed Central Full Text
  • [4]Beugnet F, Chalvet-Monfray K: Impact of climate change in the epidemiology of vector-borne diseases in domestic carnivores. Comp Immunol Microbiol Infect Dis 2013, 36(6):559-566.
  • [5]Otranto D, Dantas-Torres F, Giannelli A, Latrofa MS, Cascio A, Cazzin S, Ravagnan S, Montarsi F, Zanzani SA, Manfredi MT, Capelli G: Ticks infesting humans in Italy and associated pathogens. Parasit Vectors 2014, 7:328. BioMed Central Full Text
  • [6]Halos L, Lebert I, Chao I, Vourc’h G, Ducrot C, Abrial D, Ravier JF, Guillot J: Questionnaire-based survey on distribution and clinical incidence of canine babesiosis in France. BMC Vet Res 2013, 9:41. BioMed Central Full Text
  • [7]Yeh MT, Bak JM, Hu R, Nicholson MC, Kelly C, Mather TN: Determining the duration of Ixodes scapularis (Acari: Ixodidae) attachment to tick-bite victims. J Med Entomol 1995, 32(6):853-858.
  • [8]Halos L, Baneth G, Beugnet F, Bowman AS, Chomel B, Farkas R, Franc M, Guillot J, Inokuma H, Kaufman R, Jongejan F, Joachim A, Otranto D, Pfister K, Pollmeier M, Sainz A, Wall R: Defining the concept of ‘tick repellency’ in veterinary medicine. Parasitology 2012, 139(4):419-423.
  • [9]European Medicine Agency Committee for Medicinal Products for Veterinary Use: Guidelines for the Testing and Evaluation of the Efficacy of Antiparasitic Substances for the Treatment and Prevention of Tick and Flea Infestation in Dogs and Cats. London: European Medicine Agency; 2007. [EMA Guideline No. EMEA/CVMP/EWP/005/2000-Rev2-2007]
  • [10]Dumont P, Blair J, Fourie JJ, Chester TS, Larsen DL: Evaluation of the efficacy of afoxolaner against two European dog tick species: Dermacentor reticulatus and Ixodes ricinus. Vet Parasitol 2014, 201(3–4):216-219.
  • [11]Kondo Y, Kinoshita G, Drag M, Chester TS, Larsen D: Evaluation of the efficacy of afoxolaner against Haemaphysalis longicornis on dogs. Vet Parasitol 2014, 201(3–4):229-231.
  • [12]Kunkle B, Daly S, Dumont P, Drag M, Larsen D: Assessment of the efficacy of orally administered afoxolaner against Rhipicephalus sanguineus sensu lato. Vet Parasitol 2014, 201(3–4):226-228.
  • [13]Mitchell EB, Dorr P, Everett WR, Chester TS, Larsen D: Efficacy of afoxolaner against Dermacentor variabilis ticks in dogs. Vet Parasitol 2014, 201(3–4):220-222.
  • [14]Mitchell EB, McCall JW, Theodore Chester S, Larsen D: Efficacy of afoxolaner against Ixodes scapularis ticks in dogs. Vet Parasitol 2014, 201(3–4):223-225.
  • [15]Marchiondo AA, Holdsworth PA, Fourie LJ, Rugg D, Kellmann K, Snyder DE, Dryden MW: World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) second edition: guidelines for evaluating the efficacy of parasiticides for the treatment, prevention and control of flea and tick infestations on dogs and cats. Vet Parasitol 2013, 194:84-97.
  • [16]European Medicine Agency: VICH Topic GL9 (GCP) Guideline on Good Clinical Practices. London: European Medicine Agency; 2000. [EMWA/CVMP/VICH/595/98-Final]
  • [17]R Core Team: R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna 2013. http://www.R-project.org/ webcite
  • [18]Letendre L, Huang R, Kvaternick V, Harriman J, Drag M, Soll M: The intravenous and oral pharmacokinetics of afoxolaner used as a monthly chewable antiparasitic for dogs. Vet Parasitol 2014, 201(3–4):190-197.
  • [19]Franta Z, Frantová H, Konvičková J, Horn M, Sojka D, Mareš M, Kopáček P: Dynamics of digestive proteolytic system during blood feeding of the hard tick Ixodes ricinus. Parasit Vectors 2010, 3:119. BioMed Central Full Text
  • [20]Fourie JJ, Joubert A, Labuschagné M, Beugnet F: New method using quantitative PCR to follow the tick blood meal and to assess the anti-feeding effect of topical acaricide against Rhipicephalus sanguineus on dogs. Comp Immunol Microbiol Infect Dis 2014, 37(3):181-187.
  • [21]Beugnet F, Halos L, Larsen D, Labuschagné M, Erasmus H, Fourie J: The ability of an oral formulation of afoxolaner to block the transmission of Babesia canis by Dermacentor reticulatus ticks to dogs. Parasit Vectors 2014, 7(1):283. BioMed Central Full Text
  • [22]Ebel GD, Kramer LD: Short report: duration of tick attachment required for transmission of powassan virus by deer ticks. Am J Trop Med Hyg 2004, 71(3):268-271.
  • [23]Santos AS, Bacellar F, Santos-Silva M, Formosinho P, Grácio AJ, Franca S: Ultrastructural study of the infection process of Rickettsia conorii in the salivary glands of the vector tick Rhipicephalus sanguineus. Vector Borne Zoonotic Dis 2002, 2(3):165-177.
  • [24]Piesman J: Dynamics of Borrelia burgdorferi transmission by nymphal Ixodes dammini ticks. J Infect Dis 1993, 167(5):1082-1085.
  • [25]Hodzic E, Fish D, Maretzki CM, De Silva AM, Feng S, Barthold SW: Acquisition and transmission of the agent of human granulocytic ehrlichiosis by Ixodes scapularis ticks. J Clin Microbiol 1998, 36(12):3574-3578.
  • [26]Obsomer V, Wirtgen M, Linden A, Claerebout E, Heyman P, Heylen D, Madder M, Maris J, Lebrun M, Tack W, Lempereur L, Hance T, Van Impe G: Spatial disaggregation of tick occurrence and ecology at a local scale as a preliminary step for spatial surveillance of tick-borne diseases: general framework and health implications in Belgium. Parasit Vectors 2013, 6:190. BioMed Central Full Text
  • [27]Dantas-Torres F, Otranto D: Seasonal dynamics of Ixodes ricinus on ground level and higher vegetation in a preserved wooded area in southern Europe. Vet Parasitol 2013, 192(1–3):253-258.
  文献评价指标  
  下载次数:0次 浏览次数:6次